Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

2 clinical studies listed.

Filters:

Pharmacogenomic Testing for Medication Management

Tundra lists 2 Pharmacogenomic Testing for Medication Management clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

COMPLETED

NCT07833384

The Effect of Providing Genetic Risk Information on Lifestyle Behaviors in African Americans

Cardiovascular disease (CVD) is a major and persistent health disparity for African Americans. Linking GAINS is a randomized pilot and feasibility study designed to evaluate whether receiving genetic risk information early in a community-based CVD risk reduction intervention improves engagement and health behavior change. Sixty African American adults from the Baton Rouge metropolitan area will be recruited and randomized to a Genetically Unblinded (GU) group or a Genetically Blinded (GB) group. All participants will complete a 14-session behavioral intervention delivered over approximately 16 weeks, including culturally responsive education, nutrition and cooking sessions, physical activity training, group support, and community-based health resources. The GU group will receive genetic results and genetic counseling early in the intervention, while the GB group will receive genetic results and counseling after the behavioral intervention and end-of-study assessment. The primary endpoint is intervention engagement measured by attendance. Secondary outcomes include physical activity, dietary intake, body mass index, blood pressure, genomic orientation/knowledge, and perceived racism. Exploratory/moderator analyses will examine whether social determinants of health, including income, food insecurity, health literacy, occupational prestige, and experiences of racism, influence intervention engagement and behavior change.

Gender: All

Ages: 18 Years - Any

Updated: 2026-09-24

1 state

Diabetes
Hypercholesterolaemia
Hypertension
+11
RECRUITING

NCT02738047

Reduction of Adverse Drug Events and Readmissions

Pharmocogenomic test assessment in the medication regimen and disease management for patients under drugs known with genetic variation.

Gender: All

Ages: 25 Years - Any

Updated: 2024-02-07

1 state

Pharmacogenomic Testing for Medication Management